1123 related articles for article (PubMed ID: 1423269)
1. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
[TBL] [Abstract][Full Text] [Related]
2. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta.
Manchester DK; Bowman ED; Parker NB; Caporaso NE; Weston A
Cancer Res; 1992 Mar; 52(6):1499-503. PubMed ID: 1540958
[TBL] [Abstract][Full Text] [Related]
3. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
[TBL] [Abstract][Full Text] [Related]
4. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
5. Detection of DNA and globin adducts of polynuclear aromatic hydrocarbon diol epoxides by gas chromatography-mass spectrometry and -3H-CH3I postlabeling of released tetraols.
Melikian AA; Sun P; Coleman S; Amin S; Hecht SS
Chem Res Toxicol; 1996 Mar; 9(2):508-16. PubMed ID: 8839056
[TBL] [Abstract][Full Text] [Related]
6. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
7. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
8. Validation of a new fluorometric assay for benzo[a]pyrene diolepoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA.
Rojas M; Alexandrov K; van Schooten FJ; Hillebrand M; Kriek E; Bartsch H
Carcinogenesis; 1994 Mar; 15(3):557-60. PubMed ID: 8118943
[TBL] [Abstract][Full Text] [Related]
9. A comparison of 32P-postlabelling and immunological methods to examine human lung DNA for benzo[a]pyrene adducts.
Garner RC; Tierney B; Phillips DH
IARC Sci Publ; 1988; (89):196-200. PubMed ID: 3143669
[TBL] [Abstract][Full Text] [Related]
10. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
11. Relationships among benzo(a)pyrene metabolism, benzo(a)pyrene-diol-epoxide:DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers.
Thompson CL; McCoy Z; Lambert JM; Andries MJ; Lucier GW
Cancer Res; 1989 Dec; 49(23):6503-11. PubMed ID: 2510927
[TBL] [Abstract][Full Text] [Related]
12. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
[TBL] [Abstract][Full Text] [Related]
13. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
14. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
Li D; Wang M; Dhingra K; Hittelman WN
Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
[TBL] [Abstract][Full Text] [Related]
15. Synchronous fluorescence spectrophotometry of benzo[a]pyrene diol epoxide-DNA adducts: a tool for detection of in-vitro and in-vivo DNA damage by exposure to benzo[a]pyrene.
Vähäkangas K; Pelkonen O; Harris CC
IARC Sci Publ; 1988; (89):208-12. PubMed ID: 3143671
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
20. Benzo(a)pyrene:DNA adduct formation in early-passage Wistar rat embryo cell cultures: evidence for multiple pathways of activation of benzo(a)pyrene.
Pruess-Schwartz D; Baird WM
Cancer Res; 1986 Feb; 46(2):545-52. PubMed ID: 3940629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
